These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19634713)

  • 1. Inhalable microparticles containing isoniazid and rifabutin target macrophages and 'stimulate the phagocyte' to achieve high efficacy.
    Yadav AB; Sharma R; Muttil P; Singh AK; Verma RK; Mohan M; Patel SK; Misra A
    Indian J Exp Biol; 2009 Jun; 47(6):469-74. PubMed ID: 19634713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of apoptosis of THP-1 cells infected with Mycobacterium tuberculosis by inhalable microparticles and relevance to bactericidal activity.
    Yadav AB; Misra A
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3740-2. PubMed ID: 17664326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalable microparticles modify cytokine secretion by lung macrophages of infected mice.
    Sharma R; Yadav AB; Muttil P; Kajal H; Misra A
    Tuberculosis (Edinb); 2011 Jan; 91(1):107-10. PubMed ID: 21159559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalable microparticles containing large payload of anti-tuberculosis drugs.
    Muttil P; Kaur J; Kumar K; Yadav AB; Sharma R; Misra A
    Eur J Pharm Sci; 2007 Oct; 32(2):140-50. PubMed ID: 17681458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalable locust bean gum microparticles co-associating isoniazid and rifabutin: Therapeutic assessment in a murine model of tuberculosis infection.
    Grenha A; Alves AD; Guerreiro F; Pinho J; Simões S; Almeida AJ; Gaspar MM
    Eur J Pharm Biopharm; 2020 Feb; 147():38-44. PubMed ID: 31790800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of inhalable microparticles affects defence responses of macrophages infected with Mycobacterium tuberculosis H37Ra.
    Sharma R; Muttil P; Yadav AB; Rath SK; Bajpai VK; Mani U; Misra A
    J Antimicrob Chemother; 2007 Mar; 59(3):499-506. PubMed ID: 17242031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DRB1*1501 and VDR polymorphisms and survival of Mycobacterium tuberculosis in human macrophages exposed to inhalable microparticles.
    Singh AK; Abhimanyu ; Yadav AB; Sharma S; Garg R; Bose M; Misra A
    Pharmacogenomics; 2013 Apr; 14(5):531-40. PubMed ID: 23556450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hand-held apparatus for "nose-only" exposure of mice to inhalable microparticles as a dry powder inhalation targeting lung and airway macrophages.
    Kaur J; Muttil P; Verma RK; Kumar K; Yadav AB; Sharma R; Misra A
    Eur J Pharm Sci; 2008 May; 34(1):56-65. PubMed ID: 18387284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhalable microparticles of nitric oxide donors induce phagosome maturation and kill Mycobacterium tuberculosis.
    Verma RK; Agrawal AK; Singh AK; Mohan M; Gupta A; Gupta P; Gupta UD; Misra A
    Tuberculosis (Edinb); 2013 Jul; 93(4):412-7. PubMed ID: 23562366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhalable microparticles containing nitric oxide donors: saying NO to intracellular Mycobacterium tuberculosis.
    Verma RK; Singh AK; Mohan M; Agrawal AK; Verma PR; Gupta A; Misra A
    Mol Pharm; 2012 Nov; 9(11):3183-9. PubMed ID: 22978290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhalable chitosan microparticles for simultaneous delivery of isoniazid and rifabutin in lung tuberculosis treatment.
    Cunha L; Rodrigues S; Rosa da Costa AM; Faleiro L; Buttini F; Grenha A
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1313-1320. PubMed ID: 30990096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhalable Particles for "Pincer Therapeutics" Targeting Nitazoxanide as Bactericidal and Host-Directed Agent to Macrophages in a Mouse Model of Tuberculosis.
    Gupta A; Meena J; Sharma D; Gupta P; Gupta UD; Kumar S; Sharma S; Panda AK; Misra A
    Mol Pharm; 2016 Sep; 13(9):3247-55. PubMed ID: 27463245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spray-dried fucoidan microparticles for pulmonary delivery of antitubercular drugs.
    Cunha L; Rosa da Costa AM; Lourenço JP; Buttini F; Grenha A
    J Microencapsul; 2018 Jun; 35(4):392-405. PubMed ID: 30112917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual antibiotherapy of tuberculosis mediated by inhalable locust bean gum microparticles.
    Rodrigues S; Alves AD; Cavaco JS; Pontes JF; Guerreiro F; Rosa da Costa AM; Buttini F; Grenha A
    Int J Pharm; 2017 Aug; 529(1-2):433-441. PubMed ID: 28669623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular time course, pharmacokinetics, and biodistribution of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to mice.
    Verma RK; Kaur J; Kumar K; Yadav AB; Misra A
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3195-201. PubMed ID: 18591268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and Preclinical Evaluation of Inhalable Particles Containing Rapamycin and Anti-Tuberculosis Agents for Induction of Autophagy.
    Gupta A; Sharma D; Meena J; Pandya S; Sachan M; Kumar S; Singh K; Mitra K; Sharma S; Panda AK; Gupta P; Gupta UD; Misra A
    Pharm Res; 2016 Aug; 33(8):1899-912. PubMed ID: 27095353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytocompatibility and cellular interactions of chondroitin sulfate microparticles designed for inhaled tuberculosis treatment.
    Rodrigues S; Cunha L; Kollan J; Neumann PR; Rosa da Costa AM; Dailey LA; Grenha A
    Eur J Pharm Biopharm; 2021 Jun; 163():171-178. PubMed ID: 33838263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microparticles induce variable levels of activation in macrophages infected with Mycobacterium tuberculosis.
    Yadav AB; Muttil P; Singh AK; Verma RK; Mohan M; Agrawal AK; Verma AS; Sinha SK; Misra A
    Tuberculosis (Edinb); 2010 May; 90(3):188-96. PubMed ID: 20382085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial biodistribution and pharmacokinetics of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to rhesus macaques.
    Kumar Verma R; Mukker JK; Singh RS; Kumar K; Verma PR; Misra A
    Mol Pharm; 2012 Apr; 9(4):1011-6. PubMed ID: 22397370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhalable particles containing isoniazid and rifabutin as adjunct therapy for safe, efficacious and relapse-free cure of experimental animal tuberculosis in one month.
    Singh AK; Verma RK; Mukker JK; Yadav AB; Muttil P; Sharma R; Mohan M; Agrawal AK; Gupta A; Dwivedi AK; Gupta P; Gupta UD; Mani U; Chaudhari BP; Murthy RC; Sharma S; Bhadauria S; Singh S; Rath SK; Misra A
    Tuberculosis (Edinb); 2021 May; 128():102081. PubMed ID: 33915379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.